These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25630795)

  • 1. Cancer metabolomics in basic science perspective.
    Kwon H; Oh S; Jin X; An YJ; Park S
    Arch Pharm Res; 2015 Mar; 38(3):372-80. PubMed ID: 25630795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of metabolomics to study cancer metabolism.
    Kaushik AK; DeBerardinis RJ
    Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):2-14. PubMed ID: 29702206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prowess of metabolomics in cancer research: current trends, challenges and future perspectives.
    Taunk K; Jajula S; Bhavsar PP; Choudhari M; Bhanuse S; Tamhankar A; Naiya T; Kalita B; Rapole S
    Mol Cell Biochem; 2024 May; ():. PubMed ID: 38814423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.
    Carroll PA; Diolaiti D; McFerrin L; Gu H; Djukovic D; Du J; Cheng PF; Anderson S; Ulrich M; Hurley JB; Raftery D; Ayer DE; Eisenman RN
    Cancer Cell; 2015 Feb; 27(2):271-85. PubMed ID: 25640402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of metabolomics in drug resistant breast cancer research.
    Shajahan-Haq AN; Cheema MS; Clarke R
    Metabolites; 2015 Feb; 5(1):100-18. PubMed ID: 25693144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famine versus feast: understanding the metabolism of tumors in vivo.
    Mayers JR; Vander Heiden MG
    Trends Biochem Sci; 2015 Mar; 40(3):130-40. PubMed ID: 25639751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.
    Thapar R; Titus MA
    Curr Metabolomics; 2014 Apr; 2(1):53-69. PubMed ID: 25632377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
    Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
    Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases.
    Oh S; Mai XL; Kim J; de Guzman ACV; Lee JY; Park S
    Exp Mol Med; 2024 May; 56(5):1066-1079. PubMed ID: 38689091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia.
    Papadopoulou MT; Panagopoulou P; Paramera E; Pechlivanis A; Virgiliou C; Papakonstantinou E; Palabougiouki M; Ioannidou M; Vasileiou E; Tragiannidis A; Papakonstantinou E; Theodoridis G; Hatzipantelis E; Evangeliou A
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Metabolism and Metabolic Pathways in Prostate Cancer.
    Wanjari UR; Mukherjee AG; Gopalakrishnan AV; Murali R; Dey A; Vellingiri B; Ganesan R
    Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics in High Grade Gliomas.
    Yu N; Aboud O
    RAS Oncol Ther; 2022; 3(1):. PubMed ID: 36643416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer.
    Resurreccion EP; Fong KW
    Metabolites; 2022 May; 12(6):. PubMed ID: 35736421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics.
    Lima AR; Pinto J; Amaro F; Bastos ML; Carvalho M; Guedes de Pinho P
    Metabolites; 2021 Mar; 11(3):. PubMed ID: 33808897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncometabolites as biomarkers in thyroid cancer: a systematic review.
    Khatami F; Payab M; Sarvari M; Gilany K; Larijani B; Arjmand B; Tavangar SM
    Cancer Manag Res; 2019; 11():1829-1841. PubMed ID: 30881111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach.
    Rajasinghe LD; Hutchings M; Gupta SV
    Metabolites; 2019 Mar; 9(3):. PubMed ID: 30871192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.
    Turkoglu O; Zeb A; Graham S; Szyperski T; Szender JB; Odunsi K; Bahado-Singh R
    Metabolomics; 2016 Apr; 12(4):. PubMed ID: 28819352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: Potential application for the preoperative diagnosis of thyroid cancer.
    Ryoo I; Kwon H; Kim SC; Jung SC; Yeom JA; Shin HS; Cho HR; Yun TJ; Choi SH; Sohn CH; Park S; Kim JH
    Sci Rep; 2016 Jul; 6():30075. PubMed ID: 27440433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.
    Zhao H; Heimberger AB; Lu Z; Wu X; Hodges TR; Song R; Shen J
    Oncotarget; 2016 Apr; 7(15):20486-95. PubMed ID: 26967252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.